ALX Oncology Holdings Inc expected to post a loss of 77 cents a share - Earnings Preview

ALX Oncology Holdings

06/08/2024 12:40

* ALX Oncology Holdings Inc  ALXO.OQ   ALXO.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 8 (estimated) for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for ALX Oncology Holdings
Inc is
for a loss of 77 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ALX
Oncology
Holdings Inc is $10.00​, above​ its last closing price of $2.73.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.85       -0.84      -0.71     Beat    15.1
 Dec. 31 2024  -0.81       -0.84      -0.93     Missed  -10.5
 Sep. 30 2023  -0.82       -0.87      -1.24     Missed  -42.5​
 Jun. 30 2023  -0.88       -0.88      -0.84     Beat    4.5
 ​​Mar.        -0.82       -0.80      -0.74     Beat    7.7
 31 2023                                                
 Dec. 31 2022  -0.81       -0.89      -0.75     Beat    15.4​
 Jan. 1 0001   -0.77       -0.77      -0.87     Missed  -12.9
 Jun. 30 2022  -0.64       -0.63      -0.81     Missed  -27.9
 This summary was machine generated August 6 at 11:40 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)